FDA Import Refusal 799-3578575-0/10002/1 — CAPLIN POINT LABORATORIES LTD
The FDA refused shipment 799-3578575-0/10002/1 from CAPLIN POINT LABORATORIES LTD (India) on Nov 10, 2025. The refused product falls under Drugs and Biologics — IBUPROFEN (ANTI-INFLAMMATORY). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Nov 10, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62GDY41 IBUPROFEN (ANTI-INFLAMMATORY)
- Charges
- 75